Navigation Links
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Date:10/29/2009

tember 30, 2009 compared with $11 million for the same period in 2008.

ONCOLOGY/ENDOCRINOLOGY PRODUCTS

SUPPRELIN® LA: Net Sales of SUPPRELIN LA for the third quarter were $8 million. For the period from the acquisition date of Indevus until September 30, 2009, net sales of SUPPRELIN LA were $18 million.

VANTAS®: Net Sales of VANTAS for the third quarter were $6 million. For the period from the acquisition date of Indevus until September 30, 2009, net sales of VANTAS were $14 million.

OTHER BRANDED PRODUCTS

For the third quarter of 2009, net sales of other branded products were $4 million compared with $3 million in the same period in 2008. For the nine months ended September 30, 2009, net sales of other branded products were $12 million compared with $8 million in the same period in 2008.

GENERIC AND NON-PROMOTED PRODUCTS

For the third quarter of 2009, net sales from the company's generic products were $23 million compared with $22 million in the same period in 2008. Net sales of Percocet® were $31 million for the three months ended September 30, 2009, which is comparable to net sales of Percocet® in the same period in 2008. For the nine months ended September 30, 2009, net sales from the company's generic products were $96 million compared with $68 million in the same period in 2008. During the first half of 2009, the company benefitted from a market dislocation in the supply for certain generic products. Market conditions have now essentially normalized for these products. Net sales of Percocet® were $96 million for the nine months ended September 30, 2009, comparable to $97 million in the same period in 2008.

Conference Call Information

Endo will conduct a conference call with financial analysts to discuss this news release today at 9:00 a.m. ET. Investors and other i
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
2. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
4. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
5. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
6. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
7. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
8. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
9. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
10. BioMarin Acquires Huxley Pharmaceuticals, Inc.
11. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... MONMOUTH JUNCTION, N.J. , May 4, 2015 ... critical care immunotherapy company commercializing its CytoSorb® extracorporeal ... patients in multiple countries worldwide, will report Q1 ... Monday, May 11, 2015.  CytoSorbents, ... presentation webcast that will recount both operational and ...
(Date:5/4/2015)... , May 4, 2015 Dynatronics ... manufacturer and marketer of rehabilitation and physical therapy ... definitive agreements to raise approximately $4,000,000 in a ... and certain of its affiliates (together with its ... on the healthcare industry. The financing will provide ...
(Date:5/4/2015)... ROCKVILLE, Md. , May 4, 2015   ... of pathogen-specific therapeutics focused on protecting the microbiome, as ... Shallcross has been appointed Chief Financial Officer, Treasurer ... C. Evan Ballantyne who will be leaving the ... Mr. Shallcross brings to Synthetic Biologics operational, financial and ...
Breaking Medicine Technology:CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 3Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 4Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 2Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 3
... , Inc., a full-service contract research organization (CRO), and ... combat the growing issue of antibiotic resistance, have partnered ... walk to benefit the Cystic Fibrosis (CF) Foundation through ... Aptalis Pharma) are also working together on clinical trials ...
... May 2, 2012  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... March 31, 2012.  For the first quarter of 2012, the ... per share, compared with a net income of $2.9 million, ... 2011. This $3.8 million change in operating results is primarily ...
Cached Medicine Technology:Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure 2Neurocrine Biosciences Reports First Quarter 2012 Results 2Neurocrine Biosciences Reports First Quarter 2012 Results 3Neurocrine Biosciences Reports First Quarter 2012 Results 4Neurocrine Biosciences Reports First Quarter 2012 Results 5Neurocrine Biosciences Reports First Quarter 2012 Results 6
(Date:5/4/2015)... UT (PRWEB) May 04, 2015 Pricing ... (up to $3,000) of one patient receiving care at ... Utah. The procedure must be performed by July 15th, ... to pay in full up front and forego the filing ... becomes more economically burdensome every year, and it devastates more ...
(Date:5/4/2015)... 2015 Unlike some camps, the Nike Middle School ... The goal is to educate first and train second, with a ... that the young runners are building the knowledge base needed to ... the topics covered include Effort Based Training, Running Heroes, Running Vocabulary, ... be? This is not a camp where kids come to ...
(Date:5/4/2015)... 2015 World T.E.A.M. Sports’ best-attended ... in the last decade arrived in this historic Civil ... two days from the Pentagon in Arlington, Virginia. The ... disabled and able-bodied participants work together to successfully complete ... honors the commitment and sacrifices by military veterans in ...
(Date:5/4/2015)... 04, 2015 The Accreditation ... the first-ever congenital heart disease (CHD) standards ... (PCCL) accreditation. Driven by the latest available ... comprehensive review of interventional procedures in pediatric ... , “The ACE CHD Standards for PCCL ...
(Date:5/3/2015)... AvePoint, the established ... devices, today announced it is a Platinum Sponsor ... Asia Privacy Forum, taking place May 5-6, 2015 ... AvePoint will showcase its compliance, risk, and privacy ... Visit AvePoint for New Solutions , Attendees ...
Breaking Medicine News(10 mins):Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4Health News:Accreditation for Cardiovascular Excellence (ACE) Publishes New Standards for Pediatric and Adult Congenital Cardiac Catheterization Laboratories 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 4
... Lemon Grove Care & Rehabilitation Center has responded ... a "AA" citation issued to the 158-bed skilled ... )"We stand by the quality of care we ... the Department,s assessment of the facts surrounding this ...
... women at certain times of year, study finds , , FRIDAY, ... people,s attempts to get regular exercise, suggests a U.S. study ... and less in the winter. , The study involved ... 18 months. Based on pedometer readings, the women,s step counts ...
... College of Optometry students receive a Jenzabar Foundation grant to impact ... ... (PRWEB) February 13, 2009 -- Even in this uncertain economy, ... and wallets to volunteer for domestic and global humanitarian missions through ...
... Treat Diseases, Inc. (HTDS) ( www.htdsmedical.com ) has entered ... company that has developed a radically new product which ... the FDA approval (or authority equivalent to the specific ... FDA approved. , HTDS Andrea Zecevic-Rubio, Chief Project Scientist, ...
... 13 American Network, Inc., announced today that it ... for the Deaf and Hard of Hearing communities. ... a great success as it forays into TRS with ... and Hard of Hearing.PhoneCaption,s service uses innovative, patent-pending technology ...
... Feb. 13 Six Miami-Dade County residents have been ... fraud scheme operated out of Midway Medical, a Miami ... Acting Assistant Attorney General Rita M. Glavin of the ... the Southern District of Florida announced.Carmen Lourdes del Cueto, ...
Cached Medicine News:Health News:Lemon Grove Care & Rehabilitation Center Responds to Health Department Announcement 2Health News:Winter's Cold, Summer's Heat Take a Toll 2Health News:Cash-strapped Optometry Students Give Back in a Big Way 2Health News:Cash-strapped Optometry Students Give Back in a Big Way 3Health News:Cash-strapped Optometry Students Give Back in a Big Way 4Health News:Hard To Treat Diseases (HTDS) Negotiating to Merge with a UK Health Care Company 2Health News:PhoneCaption Provides Free Captioning Services for Deaf and Hard of Hearing 2Health News:Three Miami Physicians and Three Medical Workers Charged With $10 Million Medicare Fraud Scheme 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: